Omnicell , Inc. (NASDAQ:OMCL), a leading provider of medication management solutions in the healthcare technology sector, has been navigating a complex market environment characterized by both ...

Headquartered in Mountain View, CA, Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply ...

Perry A. Genova, PhD, will join the Company as Senior Vice President, Chief Technology Officer, on March 31, 2025. Dr. Genova ...

Omnicell (NASDAQ:OMCL – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” ...

Robust Pipeline for Advanced Services Portfolio: Omnicell’s suite of Advanced Services is a key part of the company’s medication management infrastructure to help drive improved clinical ...

Omnicell OMCL underwent analysis by 4 analysts ... The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses ...

The chief financial officer of Omnicell plans to step down sometime this year. The maker of automated medication-management systems said Wednesday that Nchacha Etta intends to depart on Sept. 15 or ...

Swiss National Bank boosted its position in Omnicell, Inc. (NASDAQ:OMCL – Free Report) by 0.9% in the fourth quarter, ...

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and ...

Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in transforming the pharmacy and nursing care delivery model, today announced that Nchacha Etta ...

Dr. Genova will lead Omnicell’s technology strategy as the Company works to address pressing issues within medication and supply management across all care settings In this role, Dr. Genova will ...